Markets:

Overview

News

Currencies

International

Treasuries

MEDIFAST INC Common Stock (NY:MED)

9.390 -0.140 (-1.47%)

Streaming Delayed Price Updated: 2:56 PM EDT, Mar 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about MEDIFAST INC Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

3 Out-of-Favor Stocks with Open Questions

March 10, 2026

The past year hasn't been kind to the stocks featured in this article. Each has tumbled to their lowest points in 12 months, leaving investors to decide whet...

Via StockStory

Medifast’s Q4 Earnings Call: Our Top 5 Analyst Questions

February 24, 2026

Medifast’s fourth quarter results outperformed Wall Street’s revenue expectations, which the market responded to positively. Management attributed this to early signs of success from its transition to...

Via StockStory

Topics Earnings

Scientific Evidence Demonstrates OPTAVIA®’s Metabolic Health Benefits, Opening the Door to Qualified HSA/FSA Clients

February 20, 2026

From Medifast

Via Business Wire

Medifast Inc (NYSE:MED) Reports Mixed Q4 Results with Deepening Losses and Challenging 2026 Outlook ↗

February 17, 2026

Via Chartmill

Earnings Scheduled For November 3, 2025 ↗

November 03, 2025

Via Benzinga

MED Q4 Deep Dive: Metabolic Health Pivot Drives Early Coach Productivity Gains

February 18, 2026

Wellness company Medifast (NYSE:MED) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, but sales fell by 36.9% year on year to $75.1 million. On the other hand, next quarter’s revenue...

Via StockStory

Medifast (MED) Q4 2025 Earnings Call Transcript ↗

February 17, 2026

Medifast (MED) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Medifast’s (NYSE:MED) Q4 CY2025 Sales Top Estimates

February 17, 2026

Wellness company Medifast (NYSE:MED) reported Q4 CY2025 results exceeding the market’s revenue expectations, but sales fell by 36.9% year on year to $75.1 million. On the other hand, next quarter’s...

Via StockStory

Medifast Announces Fourth Quarter and Full Year 2025 Financial Results

February 17, 2026

From Medifast

Via Business Wire

Earnings To Watch: Medifast (MED) Reports Q4 Results Tomorrow

February 15, 2026

Wellness company Medifast (NYSE:MED) will be reporting results this Tuesday after the bell. Here’s what to expect.

Via StockStory

Topics Artificial Intelligence

Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2025

February 03, 2026

From Medifast

Via Business Wire

3 Stocks Under $50 We Approach with Caution

February 01, 2026

Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and...

Via StockStory

1 of Wall Street’s Favorite Stock to Target This Week and 2 We Question

January 29, 2026

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional...

Via StockStory

3 Russell 2000 Stocks We’re Skeptical Of

January 20, 2026

The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher...

Via StockStory

People Magazine Spotlights Tiffany Howard’s Metabolic Health Journey with OPTAVIA®

January 16, 2026

From Medifast

Via Business Wire

OPTAVIA® Premieres Second Docuseries Episode “Health by Design: Spain” Exploring Metabolic Health and Longevity

January 15, 2026

From Medifast

Via Business Wire

3 Reasons to Avoid MED and 1 Stock to Buy Instead

January 13, 2026

Over the past six months, Medifast’s stock price fell to $11.62. Shareholders have lost 18.9% of their capital, which is disappointing considering the S&P 500 has climbed by 11.3%. This might have...

Via StockStory

Topics Stocks

Medifast Announces Planned Leadership Transition

January 05, 2026

From Medifast

Via Business Wire

1 Consumer Stock to Target This Week and 2 We Question

December 21, 2025

Consumer staples stocks are solid insurance policies in frothy markets ripe for corrections. But they’re also double-edged swords as they often lag in booming conditions, and this pattern has persisted...

Via StockStory

Topics Stocks

Q3 Earnings Highlights: Medifast (NYSE:MED) Vs The Rest Of The Personal Care Stocks

December 17, 2025

As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the personal care industry, including Medifast (NYSE:MED) and its peers.

Via StockStory

Topics Economy

OPTAVIA Survey Reveals 80% of Americans Lack Understanding of Metabolic Health Despite Its Major Impact to Overall Health and Wellbeing

December 09, 2025

From Medifast

Via Business Wire

3 Stocks Under $50 We’re Skeptical Of

December 02, 2025

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to...

Via StockStory

3 of Wall Street’s Favorite Stocks We Keep Off Our Radar

December 01, 2025

Via StockStory

3 Small-Cap Stocks That Fall Short

November 24, 2025

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a...

Via StockStory

3 Unprofitable Stocks That Fall Short

November 21, 2025

Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth.

Via StockStory

Medifast Scientific & Clinical Affairs Team Showcases New Research in Metabolic Health at ObesityWeek Conference

November 13, 2025

From Medifast

Via Business Wire

5 Insightful Analyst Questions From Medifast’s Q3 Earnings Call

November 10, 2025

Medifast’s third quarter results met Wall Street’s revenue expectations, but the market responded negatively as sales continued to decline sharply year-over-year. Management attributed these results to...

Via StockStory

Topics Earnings

MED Q3 Deep Dive: Focus Shifts to Metabolic Health Amid Industry Challenges

November 04, 2025

Wellness company Medifast (NYSE:MED) met Wall Streets revenue expectations in Q3 CY2025, but sales fell by 36.2% year on year to $89.41 million. On the other hand, next quarter’s revenue guidance of...

Via StockStory

Medifast (NYSE:MED) Posts Q3 Sales In Line With Estimates

November 03, 2025

Via StockStory

Topics Artificial Intelligence

Medifast Announces Third Quarter 2025 Financial Results

November 03, 2025

From Medifast

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.